Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Charline Degavre"'
Autor:
Katarzyna Głowacka, Sébastien Ibanez, Ophélie Renoult, Perrine Vermonden, Maria Virginia Giolito, Kübra Özkan, Charline Degavre, Léo Aubert, Céline Guilbaud, Florine Laloux-Morris, Elena Richiardone, Jérôme Ambroise, Caroline Bouzin, Davide Brusa, Jonas Dehairs, Johan Swinnen, Cyril Corbet, Yvan Larondelle, Olivier Feron
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Cancer cells in acidic tumor regions are aggressive and a key therapeutic target, but distinguishing between acid-exposed and hypoxic cells is challenging. Here, we use carbonic anhydrase 9 (CA9) antibodies to mark acidic areas in both hypox
Externí odkaz:
https://doaj.org/article/3ab569a44f3d45af8d6ab60f157e91b2
Autor:
Davide Brusa, Caroline Bouzin, Charline Degavre, Anouk Lepez, Sebastien Ibanez, Clémence François, Katarzyna Głowacka, Céline Guilbaud, Florine Laloux-Morris, Hrag Esfahani, Olivier Feron
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 11 (2024)
Background Immunogenic cell death (ICD) and ferroptosis have recently emerged as key factors in the anticancer immune response. Among the treatments able to induce ICD and the associated release of danger signals is photodynamic therapy (PDT). Ferrop
Externí odkaz:
https://doaj.org/article/2a25882a95494256802b11db717ed152
Autor:
Cyril Corbet, Estelle Bastien, Joao Pedro Santiago de Jesus, Emeline Dierge, Ruben Martherus, Catherine Vander Linden, Bastien Doix, Charline Degavre, Céline Guilbaud, Laurenne Petit, Carine Michiels, Chantal Dessy, Yvan Larondelle, Olivier Feron
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
The tumour microenvironment is known to have an acidic pH but how this influences cancer cell phenotype is unclear. Here, the authors show that tumour cells upregulate TGF-β2 under acidosis, which leads to the increased formation of lipid droplets a
Externí odkaz:
https://doaj.org/article/af7d4d7798c6436891d3d4c743591132
Autor:
Quentin Spillier, Séverine Ravez, Judith Unterlass, Cyril Corbet, Charline Degavre, Olivier Feron, Raphaël Frédérick
Publikováno v:
Pharmaceuticals, Vol 13, Iss 2, p 20 (2020)
For many years now, targeting deregulation within cancer cells’ metabolism has appeared as a promising strategy for the development of more specific and efficient cancer treatments. Recently, numerous reports highlighted the crucial role of the ser
Externí odkaz:
https://doaj.org/article/9c98f002cc4a4f8fae8c764f82e6ce92
Autor:
Charline Degavre, Olivier Feron, Caroline Bouzin, Olivier Riant, Natalia Trempolec, Bastien Doix, Davide Brusa
Publikováno v:
Cancers, Vol. 12, no. 3, p. pii:E545 (2020)
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 545 (2020)
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 545 (2020)
The potential of dendritic cell (DC)-based immunotherapy to treat cancer is, nowadays, well documented. Still, the clinical success of immune checkpoint inhibitors has dampened the interest in anticancer DC vaccination. For highly life-threatening tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::141d2443546dafb0c8589a03276adfdd
https://hdl.handle.net/2078.1/228107
https://hdl.handle.net/2078.1/228107
Autor:
Yvan Larondelle, Charline Degavre, Laurenne Petit, Joao Pedro Santiago de Jesus, Carine Michiels, Chantal Dessy, Bastien Doix, Olivier Feron, Catherine Vander Linden, Céline Guilbaud, Ruben Martherus, Estelle Bastien, Cyril Corbet, Emeline Dierge
Publikováno v:
Nature Communications, Vol. 11, no.1, p. 1 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
Nature Communications
Acidosis, a common characteristic of the tumor microenvironment, is associated with alterations in metabolic preferences of cancer cells and progression of the disease. Here we identify the TGF-β2 isoform at the interface between these observations.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68950cb71c22ec4eb3d334e9c4db980b
https://hdl.handle.net/2078.1/226540
https://hdl.handle.net/2078.1/226540
Autor:
Judith E. Unterlass, Cyril Corbet, Raphaël Frédérick, Charline Degavre, Olivier Feron, Séverine Ravez, Quentin Spillier
Publikováno v:
Pharmaceuticals
Volume 13
Issue 2
Pharmaceuticals, 2020, 13 (2), pp.20. ⟨10.3390/ph13020020⟩
Pharmaceuticals, Vol 13, Iss 2, p 20 (2020)
Volume 13
Issue 2
Pharmaceuticals, 2020, 13 (2), pp.20. ⟨10.3390/ph13020020⟩
Pharmaceuticals, Vol 13, Iss 2, p 20 (2020)
For many years now, targeting deregulation within cancer cells&rsquo
metabolism has appeared as a promising strategy for the development of more specific and efficient cancer treatments. Recently, numerous reports highlighted the crucial role of
metabolism has appeared as a promising strategy for the development of more specific and efficient cancer treatments. Recently, numerous reports highlighted the crucial role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5f53bab79a24ebbcee43efd53dd30e2
https://doi.org/10.3390/ph13020020
https://doi.org/10.3390/ph13020020